Spider venom heart drug trial could revolutionize cardiac medicine. ... The peptide comes from the venom of the K’gari funnel web spider, a species known for its potent venom.

The first drug to prevent heart attack and stroke cell damage is now one step closer to reality, after the K’gari funnel-web spider venom molecule Hi1a got a green light from independent safety ...

The molecule, a small protein called Hi1a, mimics one made by Australian funnel-web spiders. It works by preventing heart tissue from becoming too acidic during a heart attack.

Scientists in Australia are about to begin a clinical trial for a heart attack medication that was originally derived from the venom of the K’gari funnel web spider.

A molecule based on the venom of a funnel-web spider could keep cells from dying after a heart attack, having been previously shown to have similar potential after strokes.

Spider venom heart drug a step closer Date: January 17, 2024 Source: University of Queensland Summary: A molecule sourced from funnel web spider venom shows promise as a safe and effective future ...

The University of Queensland in Australia has announced the commencement of clinical trials of Hi1a, a heart drug derived from spider venom. Hi1a is a peptide found in the venom of the K'gari ...

Spider Venom Molecule Offers Promising Treatment for Heart Attacks, Strokes This study represents a significant advancement toward a potential game-changer in cardiovascular treatment.

Far from terrifying people into a heart attack, a tiny dose of venom from the much-maligned funnel-web spider may prove to be a lifesaver for people following heart attacks and strokes.

For the first time, scientists are testing whether a first-of-its-kind drug inspired by spider venom can reverse the tissue damage caused by a heart attack. Starting next summer, the team plans to ...

A spider venom molecule being investigated by an IMB team has met critical benchmarks towards becoming a treatment for heart attack and stroke. Associate Professor Nathan Palpant and Professor Glenn ...